The Budget Impact of Biosimilar Infliximab (Remsima®) for the Treatment of Autoimmune Diseases in Five European Countries

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Management of ankylosing spondylitis with infliximab2009 · 3 citations
2. 2A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis2010 · 67 citations
3. 3Early Rheumatoid Arthritis in Italy: study of incidence based on a two-level strategy in a sub-area of Florence (Scandicci-Le Signe)2008 · 19 citations
4. 4Psoriasis causes as much disability as other major medical diseases1999 · 1,504 citations
5. 5The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management2010 · 1,493 citations